Sahdev I, Brochstein J, Werther N, Stiles J, et al. Timing of Alemtuzumab With Respect to Day of Bone Marrow Infusion and its Effects Upon Engraftment and Graft-Versus-Host Disease in Patients With Sickle Cell Disease: A Single-Institutional Study. J Pediatr Hematol Oncol 2020;42:e718-e722.
PMID: 32890079